Long Non-Coding RNAs Within Macrophage-Derived Exosomes Promote BMSC Osteogenesis in a Bone Fracture Rat Model
Dong Wang,Yang Liu,Shuo Diao,Lei Shan,Junlin Zhou
DOI: https://doi.org/10.2147/ijn.s398446
IF: 7.033
2023-03-01
International Journal of Nanomedicine
Abstract:Dong Wang, Yang Liu, Shuo Diao, Lei Shan, Junlin Zhou Department of Orthopedics, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, People's Republic of China Correspondence: Junlin Zhou, Department of Orthopedics, Beijing Chaoyang hospital, Capital Medical University, 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, People's Republic of China, Tel +86-13240718193, Email Purpose: To investigate the effect of macrophage exosomal long non-coding (lnc)RNAs on bone mesenchymal stem cell (BMSC) osteogenesis and the associated mechanism. Methods: Rat BMSCs and spleen macrophages were co-cultured with serum derived from the fracture microenvironment of rat tibia. BMSC osteogenesis was evaluated using Alizarin red staining and the expression of BMP-2, RUNX2, OPN , and OC mRNA. BMSC osteogenesis was evaluated after co-culture with macrophages stimulated using hypoxic conditions or colony-stimulating factor (CSF). The uptake of macrophage-derived exosomes by BMSCs was evaluated using the exosome uptake assay. High-throughput sequencing and bioinformatics analyses were performed to identify key lncRNAs in the macrophage exosomes. The effect of lncRNA expression levels on BMSC osteogenesis was also assessed using a lncRNA overexpression plasmid and siRNA technology. M1 and M2 macrophages were distinguished using flow cytometry and the key exosomal lncRNA was detected by in situ hybridization. Results: In the fracture microenvironment, macrophages (stimulated using either hypoxia or CSF) significantly increased the osteogenic ability of BMSCs. We showed that BMSCs assimilated macrophage-derived vesicles and that the inhibition of exosomal secretion significantly attenuated the macrophage-mediated induction of BMSC osteogenesis. The hypoxia condition led to the up-regulation of 310 lncRNAs and the down-regulation of 575 lncRNAs in macrophage exosomes, while CSF stimulation caused the up-regulation of 557 lncRNAs and the down-regulation of 407 lncRNAs. In total, 108 lncRNAs were co-up-regulated and 326 lncRNAs were co-down-regulated under both conditions. We eventually identified LOC103691165 as a key lncRNA that promoted BMSC osteogenesis and was expressed at similar levels in both M1 and M2 macrophages. Conclusion: In the fracture microenvironment, M1 and M2 macrophages promoted BMSC osteogenesis by secreting exosomes containing LOC103691165. Keywords: macrophage exosomes, BMSCs osteogenesis, lncRNAs, LOC103691165, bone fracture microenvironment Bone fracture is one of the most common clinical injuries and causes of human disability. 1–3 Although fractures can be reduced and fixed, 5–10% of patients suffer from delayed fracture healing or nonunion. 3–6 Therefore, clinical and basic medical research strive to promote fracture healing, reduce nonunion rate, and accelerate the rehabilitation of patients. Bone mesenchymal stem cells (BMSCs) are the main source of osteoblasts in vivo; fracture healing is closely related to the osteogenic potential of BMSCs. 7–10 Following a fracture, local and recruited BMSCs proliferate and differentiate into osteoblasts to initiate bone repair. 9,10 Consequently, BMSCs are often used in tissue engineering to promote bone healing by implantation of materials carrying them or by direct cell injection. 2,11,12 However, their curative effect is not stable and the BMSC-mediated regulation of osteogenesis is not completely understood. Macrophages are one of the earliest cells to reach the fracture site. They secrete a variety of substances to regulate the inflammatory response and immune balance. In addition, macrophages recruit BMSCs to the site of fracture and promote their differentiation. 7,13,14 Exosomes are a type of extracellular vesicle, 40–100 nm in diameter, actively secreted by cells. 6,15,16 Exosome secretion is an important aspect of the macrophage regulatory mechanism. 15–18 Inhibiting this process results in the loss of several macrophage functions. 6,15–18 Treating macrophages with a sphingomyelinase inhibitor (GW4869), a widely recognized inhibitor of exosome secretion, dysregulates inflammatory homeostasis, immune balance, and the functions of cells such as cardiomyocytes and tumor cells. 19,20 To date, several studies have explored the regulatory effect of macrophage exosomes on BMSC osteogenesis using mouse macrophage-like cell lines (RAW 264.7 cells, tumor cells) or stem cells stimulated with macrophage colony stimulating factor (CSF). 21–24 However, these models may not accurately mimic the regulatory mechanisms of normal macrophages. In addition, the cells used in these studies were cultured in osteogenic induction medium, whic -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology